Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kenneth J Valenzano
Co-Administration With the Pharmacological Chaperone AT1001 Increases Recombinant Human Α-Galactosidase a Tissue Uptake and Improves Substrate Reduction in Fabry Mice
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Related publications
Fabry Disease: Effective Tissue Substrate Depletion Following Enzyme Replacement in Α-Galactosidase a Deficient Mice. • 607
Pediatric Research
Child Health
Pediatrics
Perinatology
Distribution of -Galactosidase a in Normal Human Kidney and Renal Accumulation and Distribution of Recombinant -Galactosidase a in Fabry Mice
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology
Receptor-Mediated Endocytosis of Α-Galactosidase a in Human Podocytes in Fabry Disease
PLoS ONE
Multidisciplinary
Adipocytes Participate in Storage in Α-Galactosidase Deficiency (Fabry Disease)
Journal of Inherited Metabolic Disease
Genetics
Prediction of Response of Mutated Alpha-Galactosidase a to a Pharmacological Chaperone
Pharmacogenetics and Genomics
Molecular Medicine
Genetics
Molecular Biology
Fabry Disease: Twenty Novel Α-Galactosidase a Mutations Causing the Classical Phenotype
Journal of Human Genetics
Genetics
Impact of Cysteine Variants on the Structure, Activity, and Stability of Recombinant Human Α-Galactosidase A
Protein Science
Biochemistry
Medicine
Molecular Biology
Strong Increase of Leukocyte Apha‐galactosidase a Activity in Two Male Patients With Fabry Disease Following Oral Chaperone Therapy
Molecular genetics & genomic medicine
Genetics
Molecular Biology
Monoclonal Antibody Po66 Uptake by Human Lung Tumours Implanted in Nude Mice: Effect of Co-Administration With Doxorubicin
British Journal of Cancer
Cancer Research
Oncology
